No internet connection — showing the saved version of the page.

Cencora, Inc.

USUSD
← to the screener
US:CORLSE:0HF3

Cencora, Inc. (LSE:0HF3) — Other Pharmaceuticals. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
cencora.com
Sector
Health Care · Other Pharmaceuticals
Headquarters
Chesterbrook, United States
CEO
Steven H. Collis
Employees
44 000
Founded
2001
Shares outstanding
190.83 M as of 2026-07-31
Free float
180.25 M
Market cap
58.98 B USD
Insiders
4.3%
Institutions
99.63%
Industry (SIC)
Wholesale-Drugs, Proprietaries & Druggists' Sundries
ISIN
US03073E1055
LEI
AI8GXW8LG5WK7E9UD086
Payout ratio
17.8%
FCF
4.06 B USD
12%
Debt
11.7 B USD
2.2 y of FCF
Dividend streak
25 y
Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
Description

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksCOR primaryUSD323.85 +0.78%common stock
LSE London Stock Exchange0HF3 IOBUSD304.73 +0.00%common stock

Price for 3 months

up day down day dividend ex-date payment dateHover / tap a day — open, close, high and low prices

Dividends

Per year, US:COR: 2.4 USD (4 paym.)

Cencora, Inc. (COR) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 2.4 USD per share (payments: 4). That is about 0.74% of the current share price. Based on payment history, the next ex-dividend date is expected around 13.11.2026. Uninterrupted dividend history: 25 years.

Ex-datePaymentAmount%TypeTicker
2026-08-142026-08-310.6000 USD0.2/0.7 %quarterlyUS:COR
2026-05-152026-06-010.6000 USD0.2/0.7 %quarterlyUS:COR
2026-02-132026-03-020.6000 USD0.2/0.7 %quarterlyUS:COR
2025-11-142025-12-010.6000 USD0.2/0.7 %quarterlyUS:COR
2025-08-152025-09-030.5500 USD0.2/0.7 %quarterlyUS:COR
2025-05-162025-06-020.5500 USD0.2/0.7 %quarterlyUS:COR
2025-02-142025-03-030.5500 USD0.2/0.7 %quarterlyUS:COR
2024-11-152024-11-290.5500 USD0.2/≈0.7 %quarterlyUS:COR
2024-08-092024-08-260.5100 USD0.2/≈0.6 %quarterlyUS:COR
2024-05-092024-05-240.5100 USD0.2/≈0.6 %quarterlyUS:COR

Top holders

HolderStakeSharesReport date
BlackRock9.54%18.21 M2026-06-30
Vanguard Capital Managem…6.49%12.38 M2026-06-30
Vanguard Portfolio Manag…5.04%9.61 M2026-06-30
State Street Corporation4.86%9.27 M2026-06-30
T. Rowe Price Investment…3.88%7.41 M2026-06-30
Price (T.Rowe) Associate…3.74%7.13 M2026-06-30
JPMORGAN CHASE & CO3.11%5.94 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.07%5.87 M2026-06-30
Geode Capital Management…2.86%5.45 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.64%5.04 M2026-06-30
Boston Partners2.55%4.87 M2026-06-30
Wellington Management Gr…2.39%4.56 M2026-06-30
T. ROWE PRICE CAPITAL AP…2.33%4.44 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.1%4.01 M2026-06-30
VANGUARD SPECIALIZED FUN…1.59%3.03 M2026-07-31
iShares Trust-iShares Co…1.36%2.59 M2026-08-31
Fidelity Concord Street…1.32%2.52 M2026-07-31
SPDR S&P 500 ETF TRUST-S…1.25%2.38 M2026-08-31
VANGUARD INDEX FUNDS-Van…0.92%1.76 M2026-06-30
-Price (T.Rowe) U.S. Val…0.85%1.62 M2026-06-30
COLLIS STEVEN HOWARD (Of…≈0.16%305 9132025-09-16
CLEARY JAMES F. JR. (Chi…≈0.08%160 3572026-03-11
MAUCH ROBERT P. (Chief E…≈0.03%65 3932026-02-20
DURCAN DERMOT MARK (Dire…≈0.02%31 7672026-06-18
BATTAGLIA SILVANA (Offic…≈0.01%23 6242026-06-30
CAMPBELL ELIZABETH S (Of…≈0.01%19 4552026-08-24
GREENBERG LON R (Directo…≈0.01%17 1282026-09-16
KRIKORIAN LAZARUS (Offic…≈0.01%16 1692026-09-01
NALLY DENNIS M (Director…≈0.01%13 1882026-07-31
The Vanguard Group———
Walgreens Boots Alliance…——2025-02-06